ARTICLE | Company News
Indel Therapeutics, Simon Fraser University, University of British Columbia infectious news
September 17, 2012 7:00 AM UTC
The universities partnered with Indel to identify targets and compounds to treat antibiotic-resistant nosocomial pathogens, or hospital-acquired infections. In June, the universities received a fundin...